Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to B-cell Lymphoma
Related studies linked through entity extraction aliases.
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Venetoclax Plus Inotuzumab for B-ALL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
CD19 and BCMA Targeted Fast Dual CAR-T for CD19+ Refractory/Relapsed B-NHL
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- N/A
Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA
- Status
- UNKNOWN
- Phase
- PHASE3
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
CD19/CD20 Dual-CAR-T in B-cell Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
PD1-CD19-CART in Patients With r/r B-cell Lymphoma
- Status
- COMPLETED
- Phase
- NA